SAR131675, a VEGRF3 Inhibitor, Modulates the Immune Response and Reduces the Growth of Colorectal Cancer Liver Metastasis

SIMPLE SUMMARY: Colorectal cancer most often metastasizes to the liver, and in most cases, it is unresectable at diagnosis. New treatment options targeting specific cancer characteristics are needed and are currently being explored. Herein we looked at the use of a selective VEGFR-3 tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Katrina A., Kastrappis, Georgios, Fifis, Theodora, Paolini, Rita, Christophi, Christopher, Perini, Marcos V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179346/
https://www.ncbi.nlm.nih.gov/pubmed/35681695
http://dx.doi.org/10.3390/cancers14112715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179346/
https://www.ncbi.nlm.nih.gov/pubmed/35681695
http://dx.doi.org/10.3390/cancers14112715

Ejemplares similares